It was recently demonstrated that 7,8-dihydroxyflavone (7,8-DHF), a novel stroke medication permeable to the membrane and able to cross the blood–brain barrier (BBB), acts as a BDNF mimetic to reduce depression-like behavior in mice and rats [53,54]. This evidence concerns the gene BDNF and depressive symptom measurement.